Literature DB >> 25784093

Induction of T regulatory subsets from naïve CD4+ T cells after exposure to breast cancer adipose derived stem cells.

Mahboobeh Razmkhah1, Nadieh Abedi, Ahmad Hosseini, Mohammad Taghi Imani, Abdol-Rasoul Talei, Abbas Ghaderi.   

Abstract

BACKGROUND: Adipose derived stem cells (ASCs) provoke the accumulation and expansion of regulatory T cells, leading to the modulation of immune responses in tumor microenvironment.
OBJECTIVE: To assess the effect of tumoral ASCs on the trend of regulatory T cells differentiation.
METHODS: Peripheral blood naïve CD4+ T cells were co-cultured with ASCs derived from breast cancer or normal breast tissues. In separate cultures peripheral blood naïve CD4+ T cells were exposed to the culture supernatants of ASCs.
RESULTS: Generation of CD4+CD25+Foxp3+ and CD4+CD25-Foxp3+ Treg subsets was observed after coculture of naïve CD4+ T cell with either ASCs or the related supernatant. The percentage of CD4+CD25+Foxp3+ cells increased after exposing naïve CD4+ T cells to both ASCs and their supernatants while augmentation of CD4+CD25-Foxp3+ subset mostly depended on the presence of ASCs. Similarly, upregulation of FoxP3 molecule was more significant in condition of cell to cell contact. IL-4 and IL-10 were up-regulated in the cocultured naïve CD4+ T cells after exposure to ASCs/supernatant while IFN-γ was down-regulated in the presence of ASCs.
CONCLUSION: ASC may act as one of the major players in tumor site with immunomodulatory effects, which may mostly be carried out through direct cell-cell interaction.

Entities:  

Mesh:

Year:  2015        PMID: 25784093     DOI: IJIv12i1A1

Source DB:  PubMed          Journal:  Iran J Immunol        ISSN: 1735-1383            Impact factor:   1.603


  5 in total

1.  Adipose-mesenchymal stromal cells suppress experimental Sjögren syndrome by IL-33-driven expansion of ST2+ regulatory T cells.

Authors:  Ousheng Liu; Junji Xu; Fu Wang; Wenwen Jin; Peter Zanvit; Dandan Wang; Nathan Goldberg; Alexander Cain; Nancy Guo; Yichen Han; Andrew Bynum; Guowu Ma; Songlin Wang; Zhangui Tang; Wanjun Chen
Journal:  iScience       Date:  2021-04-16

2.  Growth suppression effect of human mesenchymal stem cells from bone marrow, adipose tissue, and Wharton's jelly of umbilical cord on PBMCs.

Authors:  Maryam Ayatollahi; Tahereh Talaei-Khozani; Mahboobeh Razmkhah
Journal:  Iran J Basic Med Sci       Date:  2016-02       Impact factor: 2.699

3.  Helios, CD73 and CD39 Induction in Regulatory T Cells Exposed to Adipose Derived Mesenchymal Stem Cells.

Authors:  Maryam Fakhimi; Abdol Rasoul Talei; Abbas Ghaderi; Mojtaba Habibagahi; Mahboobeh Razmkhah
Journal:  Cell J       Date:  2019-10-14       Impact factor: 2.479

4.  Adipose-derived mesenchymal stem cells (AD-MSCs) in the treatment for psoriasis: results of a single-arm pilot trial.

Authors:  Danni Yao; Shuyan Ye; Ziyang He; Yu Huang; Jingwen Deng; Zehuai Wen; Xinsheng Chen; Hongyi Li; Qin Han; Hao Deng; Robert Chunhua Zhao; Chuanjian Lu
Journal:  Ann Transl Med       Date:  2021-11

Review 5.  The Crosstalk Between Adipose-Derived Stem or Stromal Cells (ASC) and Cancer Cells and ASC-Mediated Effects on Cancer Formation and Progression-ASCs: Safety Hazard or Harmless Source of Tropism?

Authors:  Vincent G J Guillaume; Tim Ruhl; Anja M Boos; Justus P Beier
Journal:  Stem Cells Transl Med       Date:  2022-04-29       Impact factor: 7.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.